Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03850795
Title HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Hinova Pharmaceuticals USA, Inc.
Indications

prostate cancer

Therapies

Enzalutamide

HC-1119

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | AUT


No variant requirements are available.